Clinical research in rare endocrine conditions like endogenous Cushing’s syndrome and acromegaly calls for rare focus. Strongbridge brings that focus to developing a pipeline of innovative treatments for rare disease.
At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.
The Strongbridge team is passionate about making a positive difference in the lives of patients with rare diseases. It’s why we’re here.